X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

MREO

Closed

Mereo Biopharma Group Plc Adr

2.76
+0.05 (+1.85%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 2.71
Day's Range: 2.6604 - 2.86
Send
When Written:
 
0.8883
Mereo BioPharma Group PLC is a clinical-stage biopharmaceutical company that focuses on developing and commercializing innovative therapeutics for rare and specialty diseases. The company's pipeline includes several product candidates in various stages of development, targeting diseases such as osteogenesis imperfecta, alpha-1 antitrypsin deficiency, and hypogonadotropic hypogonadism. Mereo BioPharma Group PLC is headquartered in London, UK, and its American Depositary Receipts (ADRs) trade on the NASDAQ stock exchange under the ticker symbol "MREO."

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X